Novo Integrated Sciences Total Liabilities 2012-2024 | NVOS

Novo Integrated Sciences total liabilities from 2012 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Novo Integrated Sciences Annual Total Liabilities
(Millions of US $)
2023 $11
2022 $19
2021 $18
2020 $6
2019 $7
2018 $5
2017 $10
2016 $0
2016 $10
2015 $0
2014 $1
2013 $1
2012 $1
2012 $
2011 $2
2011 $
Novo Integrated Sciences Quarterly Total Liabilities
(Millions of US $)
2024-05-31 $26
2024-02-29 $13
2023-11-30 $14
2023-08-31 $11
2023-05-31 $9
2023-02-28 $10
2022-11-30 $17
2022-08-31 $19
2022-05-31 $27
2022-02-28 $26
2021-11-30 $20
2021-08-31 $18
2021-05-31 $6
2021-02-28 $6
2020-11-30 $6
2020-08-31 $6
2020-05-31 $6
2020-02-29 $6
2019-11-30 $7
2019-08-31 $7
2019-05-31 $6
2019-02-28 $4
2018-11-30 $5
2018-08-31 $5
2018-05-31 $5
2018-02-28 $5
2017-11-30 $9
2017-08-31 $10
2017-05-31 $10
2017-03-31 $0
2017-02-28
2016-12-31
2016-11-30
2016-09-30 $0
2016-06-30 $0
2016-05-31
2016-03-31 $0
2015-12-31
2015-09-30 $0
2015-06-30 $0
2015-03-31 $0
2014-12-31
2014-09-30 $1
2014-06-30 $1
2014-03-31 $1
2013-12-31
2013-09-30 $1
2013-06-30 $1
2013-03-31 $1
2012-12-31 $1
2012-09-30 $1
2012-08-31
2012-06-30 $1
2012-03-31 $2
2012-02-29
2011-12-31 $2
2011-11-30
2011-09-30
2011-08-31 $0
2011-06-30
2011-05-31 $0
2011-03-31
2011-02-28 $0
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.001B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.039B 12.12
Quest Diagnostics (DGX) United States $17.877B 18.12
DaVita (DVA) United States $12.667B 16.38
Encompass Health (EHC) United States $10.405B 24.53
Chemed (CHE) United States $8.459B 26.00
Elanco Animal Health (ELAN) United States $7.054B 16.79
RadNet (RDNT) United States $6.388B 141.61
Option Care Health (OPCH) United States $3.890B 18.43
Amedisys (AMED) United States $3.035B 21.60
LifeStance Health (LFST) United States $2.828B 0.00
Addus HomeCare (ADUS) United States $2.320B 27.22
Astrana Health (ASTH) United States $2.297B 36.01
U.S Physical Therapy (USPH) United States $1.428B 37.54
Pennant (PNTG) United States $1.162B 46.99
Aveanna Healthcare Holdings (AVAH) United States $1.149B 0.00
Atai Life Sciences (ATAI) Germany $0.265B 0.00
Daxor (DXR) United States $0.042B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00